NPY5R and cancer: NPY1R did not colocalize more with hypoxic tumor regions across cancer stages (Fig. 7A), but NPY5R significantly colocalized with hypoxia in stage T3 tumors by 6.53-fold relative to normal breast tissue (Fig. 7B).